We hereby collected the PFS data of nearly 800 NSCLC patients treated with anti-PD-(L)1 monotherapy and evaluated the interaction effects with more than 20 co-mutated samples separately in nonsquamous and squamous NSCLC. Here, CD274 is linked to non-small cell lung carcinoma.